Literatur
Brunner T, Grabenbauer GG, Jung A, Steininger H, Kirchner T, Sauer S. p53 PCNA, ki-67 in head and neck carcinoma. Eur J Cancer 1997;33:Suppl 8:S183.
Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ. Loss of tumor-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 1996;88:1054–9.
Koch WM, Brennan JA, Zahurak M et al.: p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:1580–6.
Kokoska MS, Piccirillo JF, Elmofty SK, Emami B, Haughey BH, Scholnick SB. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy. Cancer 1996;78:1693–700.
Kropveld A, van Mansfeld ADM, Nabben N, Hordijk GJ, Slootweg PJ. Discordance of p53 status in matched primary tumours and me tastases in head and neck squamous cell carcinoma patients. Eur J Cancer 1996;32B:388–93.
Raybaud-Diogène H, Fortin A, Morency R, Roy J, Monteil RA, Têtu B. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol 1997;15:1030–8.
Tan LKS, Ogden GR. p53 over expression in laryngeal carcinoma is not predictive of response to radiotherapy. Oral-Oncol 1997;33:177–81.
Wilson GD, Richman PI, Dische S et al. p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. Br J Cancer 1995;71:1248–52.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Budach, W. „Marker” der Strahlenresistenz bei Plattenepithelkarzinomen im Kopf-Hals-Bereich: eine klinisch-pathologische und immunhistochemische Studie. Strahlenther Onkol 174, 286–288 (1998). https://doi.org/10.1007/BF03038724
Issue Date:
DOI: https://doi.org/10.1007/BF03038724